Health In Tech closed at $0.60 on Nov 4, up 4.13%, 79.7% below its 52-week closing high. Volume of 49.6K shares was 0.75× its 20-day average (below normal).
Split-adjusted performance: -26.2% over one month, -60.7% over six months, -77.9% over one year.
In the quarter ended Jun 30, 2026, revenue was $8.06M, down 13.5% from a year earlier, with a net margin of -31.2%.
Short interest was 423.3K shares at the Oct 15 settlement, up 3.6% from the prior report (2.3% of float, 2.6 days to cover).